scispace - formally typeset
M

Michel Rivoire

Researcher at French Institute of Health and Medical Research

Publications -  151
Citations -  4441

Michel Rivoire is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: High-intensity focused ultrasound & Medicine. The author has an hindex of 31, co-authored 132 publications receiving 3616 citations. Previous affiliations of Michel Rivoire include University of Lyon.

Papers
More filters
Journal ArticleDOI

Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control

TL;DR: Compartmental resection is a significant variable, predicting a 3.29-fold lower rate of abdominal recurrence compared with simple complete resection and should be performed when possible to achieve clear margins.
Journal ArticleDOI

Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model

TL;DR: HR for NCNELM is safe and effective, with outcomes mainly dependent on primary tumor site and histology, and a statistical model based on key prognostic factors could validate the indication for hepatic resection by predicting long-term survivals.
Journal ArticleDOI

Autologous latissimus breast reconstruction : A 3-year clinical experience with 100 patients

TL;DR: The best indications of this technique are when one can bury the cutaneous paddle: cases of skin‐sparing mastectomy, cases where the latissimus dorsi flap can be combined with an abdominal advancement flap, and cases of conversion of implant reconstruction to an autologous reconstruction.
Journal ArticleDOI

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

TL;DR: A prospective, randomised, open-label, multicentre, phase 3 trial at 15 tertiary centres in France that were experts in the treatment of rectal cancer failed to show superiority of local excision over total mesorectal excision in patients with a good response after chemoradiotherapy.
Journal ArticleDOI

Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group.

TL;DR: In pN0 patients, R1 resection is the strongest independent predictor of poor outcome and a margin of at least 5 mm should be created, while in patients undergoing surgery for IHCC, the survival benefits of resection in pN+ patients and R1 surgery in general are very low.